An introduction to HTA, Early HTA, and patient preference evidence for demonstrating the value of repurposed medicines. Repurposing has the potential to bring treatments to patients more quickly and efficiently....

Are you an early career researcher (ECR) who wants to delve into drug repurposing?   Join us for the third REMEDi4ALL Hackathon, 6-11 September 2026, held at Hotel Checkin Montserrat,...

The Hungarian Health Economics Association (META) is pleased to invite patients, carers, patient organisation representatives, clinicians, HTA professionals and other interested stakeholders to its next online webinar. The participation of...

A study that is suitable for publication or guideline development is not automatically suitable for marketing authorisation. Hellen Houlleberghs, Orfenix’ s clinical director will discuss what changes when the goal...

On 5 November 2026, the Global Pharmaceutical and Society Studies (GPSS) Network will run a closed, interactive workshop with 50 participants under Chatham House rules at the Humanity Hub, The Hague, the...

Join the REMEDi4ALL Repurposing Bootcamp and lead the way in innovative treatment strategies. The REMEDi4ALL Repurposing Bootcamp is a specialised training programme designed to empower patient representatives with the essential knowledge and...

As in previous editions,  #iDR27 will feature a pre-conference meeting dedicated to the REMEDi4ALL Funders Network on Monday 14 June.  More information about this event, including a link to the registration form, will...

Join the leading international drug repurposing conference by REMEDi4ALL and Beacon for Rare Diseases to explore how we can move promising science, ideas, and collaborations further towards patient impact.  #iDR27...